Complexity of the pharmaceutical supply chain
The drug supply chain involves dozens of entities: active pharmaceutical ingredient (API) suppliers, excipient manufacturers, contract manufacturing organizations (CMOs), contract laboratories, pharmaceutical wholesalers, and pharmacies. Each entity is a potential attack vector. An attack on a single API supplier in Asia can halt drug production across Europe. The Falsified Medicines Directive (FMD) and serialization system add another layer of digital infrastructure requiring protection.
Supply chain threats
Attacks on API suppliers
Active ingredient suppliers — often from China and India — may have weaker IT security. Compromising their ERP systems gives access to formulation information and orders.
Serialization system manipulation
The drug authentication verification system (FMD/EMVS) relies on 2D codes and databases. An attack could enable introducing counterfeit drugs into legitimate distribution.
Cold chain logistics attacks
Manipulating temperature monitoring systems in the cold chain — altered data allows distribution of drugs stored in improper conditions.
Ransomware at a distributor
An attack on a pharmaceutical wholesaler paralyzes drug deliveries to hospitals and pharmacies. In 2024, such an attack caused week-long shortages in several EU countries.
Supply chain protection methods
-
Supplier risk assessment — regular cybersecurity audits of critical suppliers. Security questionnaires, certificate verification (ISO 27001), penetration testing.
-
Secure data exchange — encrypted communication channels with suppliers (site-to-site VPN, SFTP). Eliminate email as a critical data transfer channel.
-
Supplier access segmentation — suppliers and partners access only necessary systems. Zero Trust for external connections.
-
Serialization integrity monitoring — verifying data consistency in FMD/EMVS systems. Alerts on scanning anomalies.
-
Supply chain continuity plan — alternative API suppliers, safety stock, procedures for cyberattack at a partner.
-
Cybersecurity clauses in contracts — NIS2 requirements for suppliers, incident reporting obligations, audit rights.
Cybersecurity for Your Industry
Learn more about cybersecurity in your industry:
Why this matters for organizations
The pharmaceutical supply chain is vulnerable to cyberattacks — from API suppliers to distribution. Learn threats and protection methods. In the context of growing cyber threats and tightening regulations (NIS2, DORA), organizations must proactively manage this security area. Failure to implement adequate safeguards can lead to data breaches, financial penalties, and reputational damage.
Best practices for implementation
Effective implementation requires several key steps:
- Risk assessment and inventory — identify assets, threats, and vulnerabilities specific to your organization.
- Policy development — document requirements, roles, and responsibilities.
- Technical controls — deploy tools and configurations proportionate to identified risks.
- Training and awareness — engage employees in protecting organizational security.
- Monitoring and continuous improvement — regularly verify effectiveness and adapt to the evolving threat landscape.
Related topics
See also:
Related terms
Our services
- NIS2 for hospitals — implementation and compliance
- NIS2 for local government — municipalities implementation
